CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Additional Paid-In Capital	Accumulated Deficit	Noncontrolling Interests	Common Stock Common Class A	Previously Reported	Previously Reported Series A	Previously Reported Series B	Previously Reported Series C	Previously Reported Additional Paid-In Capital	Previously Reported Accumulated Deficit	Previously Reported Noncontrolling Interests	Previously Reported Common Stock Common Class A	Previously Reported Common Stock Common Class B	Revision of Prior Period Adjustment Series A	Revision of Prior Period Adjustment Series B	Revision of Prior Period Adjustment Series C	Revision of Prior Period Adjustment Additional Paid-In Capital	Revision of Prior Period Adjustment Common Stock Common Class A	Revision of Prior Period Adjustment Common Stock Common Class B
Beginning balance at Dec. 31, 2020	$ 32,904	$ 96,880	$ (63,983)	$ (3)	$ 10	$ 32,904				$ 96,870	$ (63,983)	$ (3)		$ 8				$ 10	$ 10	$ (8)
Temporary equity beginning balance (in Shares) at Dec. 31, 2020							5,421,446	3,158,338	3,532,228						(5,421,446)	(3,158,338)	(3,532,228)
Temporary equity beginning balance at Dec. 31, 2020							$ 5	$ 3	$ 4						$ (5)	$ (3)	$ (4)
Beginning balance (in Shares) at Dec. 31, 2020					104,039,354								171,645	8,000,001					103,867,709	(8,000,001)
Purchase of non-controlling interest	(200)	(203)		$ 3
Stock-based compensation	173	173
Exercise of stock options	20	20
Exercise of stock options (in Shares)					24,618
Net loss	(5,198)		(5,198)
Ending balance at Mar. 31, 2021	27,699	96,870	(69,181)		$ 10
Ending balance (in Shares) at Mar. 31, 2021					104,063,972
Stock-based compensation	219	219
Net loss	(5,263)		(5,263)
Ending balance at Jun. 30, 2021	22,655	97,089	(74,444)		$ 10
Ending balance (in Shares) at Jun. 30, 2021					104,063,972
Beginning balance at Dec. 31, 2021	213,962	359,439	(145,491)		$ 14
Beginning balance (in Shares) at Dec. 31, 2021					137,722,658
Stock-based compensation	10,850	10,850
Common stock issued upon vesting of restricted stock awards and restricted stock units (in Shares)					2,013,893
Shares repurchased for payment of tax withholdings and other	(5,250)	(5,250)
Shares repurchased for payment of tax withholdings and other (in Shares)					793,888
Exercise of stock options	65	65
Exercise of stock options (in Shares)					83,582
Net loss	(19,202)		(19,202)
Ending balance at Mar. 31, 2022	200,425	365,104	(164,693)		$ 14
Ending balance (in Shares) at Mar. 31, 2022					139,026,245
Beginning balance at Dec. 31, 2021	$ 213,962	359,439	(145,491)		$ 14
Beginning balance (in Shares) at Dec. 31, 2021					137,722,658
Exercise of stock options (in Shares)	1,575,984
Ending balance at Jun. 30, 2022	$ 246,277	434,073	(187,811)		$ 15
Ending balance (in Shares) at Jun. 30, 2022					152,229,803
Beginning balance at Mar. 31, 2022	200,425	365,104	(164,693)		$ 14
Beginning balance (in Shares) at Mar. 31, 2022					139,026,245
Stock-based compensation	10,270	10,270
Common stock issued upon vesting of restricted stock awards and restricted stock units (in Shares)					1,402,863
Shares repurchased for payment of tax withholdings and other	(1,342)	(1,342)
Shares repurchased for payment of tax withholdings and other (in Shares)					464,381
Exercise of stock options	486	486
Exercise of stock options (in Shares)					1,492,402
Common stock and assumed equity awards as consideration for an acquisition of a business	59,556	59,555			$ 1
Common stock and assumed equity awards as consideration for an acquisition of a business (In Shares)					10,772,674
Net loss	(23,118)		(23,118)
Ending balance at Jun. 30, 2022	$ 246,277	$ 434,073	$ (187,811)		$ 15
Ending balance (in Shares) at Jun. 30, 2022					152,229,803